IP Verse

Amgen vs. Regeneron Pharmaceuticals - UPC_COA_646/2025

The UPC Case UPC_COA_646/2025 was filed on 11 Jul, 2025 by the plaintiff Amgen against the defendant Regeneron Pharmaceuticals.

Case Details

    Case Number:

    UPC_COA_646/2025

    Patent Number:

    EP3536712

    Filing Date:

    11 Jul, 2025

    Proceeding Type:

    Appeal

    Case Phase:

    Written Phase

    Plaintiffs:

    • Amgen

    Plaintiff Representatives:

    • Johannes HESELBERGER

    Defendants:

    • Regeneron Pharmaceuticals

    Defendant Representatives:

    • Niels HOELDER

    Judges:

    • Cornelis Schüller
    • Ingeborg Simonsson
    • Patricia Rombach
    • Rainer Friedrich
    • Rian Kalden

Case Decision

Decision pending - set alert to receive updates

Docket Entries

The docket entries provide a comprehensive overview of all filings, motions, orders, and other significant actions taken in the case.

DateTitleLink
Sep 18, 2025Panel Appointment-
Sep 18, 2025Acknowledgement Of Lodging-
Sep 15, 2025Statement Of Grounds Of Appeal Cfr En-
Sep 15, 2025Acknowledgement Of Lodging-
Sep 10, 2025Order On Stay
Sep 4, 2025Exhibit Bp86 Amgen-
Sep 4, 2025Appeal Comments To Orders Amgen En-
Aug 28, 2025.08.28 Sanofi Regeneron Comments On Possibility Of A Stay Signed-
Aug 22, 2025Case Management Order-
Jul 15, 2025Receipt-
Jul 15, 2025Panel Appointment-
Jul 15, 2025Formal Checks Notification Of Positive Outcome-
Jul 11, 2025Exhibit Bp00 Proof Of Payment 32765 2025-
Jul 11, 2025Acknowledgement Of Lodging-
Jul 11, 202520250711 Statement Of Appeal Amgen 32765 2025-
Sep 18, 2025Panel Appointment-
Sep 18, 2025Acknowledgement Of Lodging-
Sep 15, 2025Statement Of Grounds Of Appeal Cfr En-
Sep 15, 2025Acknowledgement Of Lodging-
Sep 10, 2025Order On Stay
Sep 4, 2025Exhibit Bp86 Amgen-
Sep 4, 2025Appeal Comments To Orders Amgen En-
Aug 28, 2025.08.28 Sanofi Regeneron Comments On Possibility Of A Stay Signed-
Aug 22, 2025Case Management Order-
Jul 15, 2025Receipt-
Jul 15, 2025Panel Appointment-
Jul 15, 2025Formal Checks Notification Of Positive Outcome-
Jul 11, 2025Exhibit Bp00 Proof Of Payment 32765 2025-
Jul 11, 2025Acknowledgement Of Lodging-
Jul 11, 202520250711 Statement Of Appeal Amgen 32765 2025-
Sep 18, 2025Panel Appointment-
Sep 18, 2025Acknowledgement Of Lodging-
Sep 15, 2025Statement Of Grounds Of Appeal Cfr En-
Sep 15, 2025Acknowledgement Of Lodging-
Sep 10, 2025Order On Stay
Sep 4, 2025Exhibit Bp86 Amgen-
Sep 4, 2025Appeal Comments To Orders Amgen En-
Aug 28, 2025.08.28 Sanofi Regeneron Comments On Possibility Of A Stay Signed-
Aug 22, 2025Case Management Order-
Jul 15, 2025Receipt-
Jul 15, 2025Panel Appointment-
Jul 15, 2025Formal Checks Notification Of Positive Outcome-
Jul 11, 2025Exhibit Bp00 Proof Of Payment 32765 2025-
Jul 11, 2025Acknowledgement Of Lodging-
Jul 11, 202520250711 Statement Of Appeal Amgen 32765 2025-
Sep 18, 2025Panel Appointment-
Sep 18, 2025Acknowledgement Of Lodging-
Sep 15, 2025Statement Of Grounds Of Appeal Cfr En-
Sep 15, 2025Acknowledgement Of Lodging-
Sep 10, 2025Order On Stay
Sep 4, 2025Exhibit Bp86 Amgen-
Sep 4, 2025Appeal Comments To Orders Amgen En-
Aug 28, 2025.08.28 Sanofi Regeneron Comments On Possibility Of A Stay Signed-
Aug 22, 2025Case Management Order-
Jul 15, 2025Receipt-
Jul 15, 2025Panel Appointment-
Jul 15, 2025Formal Checks Notification Of Positive Outcome-
Jul 11, 2025Exhibit Bp00 Proof Of Payment 32765 2025-
Jul 11, 2025Acknowledgement Of Lodging-
Jul 11, 202520250711 Statement Of Appeal Amgen 32765 2025-
Sep 18, 2025Panel Appointment-
Sep 18, 2025Acknowledgement Of Lodging-
Sep 15, 2025Statement Of Grounds Of Appeal Cfr En-
Sep 15, 2025Acknowledgement Of Lodging-
Sep 10, 2025Order On Stay
Sep 4, 2025Exhibit Bp86 Amgen-
Sep 4, 2025Appeal Comments To Orders Amgen En-
Aug 28, 2025.08.28 Sanofi Regeneron Comments On Possibility Of A Stay Signed-
Aug 22, 2025Case Management Order-
Jul 15, 2025Receipt-
Jul 15, 2025Panel Appointment-
Jul 15, 2025Formal Checks Notification Of Positive Outcome-
Jul 11, 2025Exhibit Bp00 Proof Of Payment 32765 2025-
Jul 11, 2025Acknowledgement Of Lodging-
Jul 11, 202520250711 Statement Of Appeal Amgen 32765 2025-

More cases involving EP3536712B1

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 9, 2025
Case NumberFiling DatePlaintiffsDefendants
APL_32715/2025Jul 14, 2025Regeneron Pharmaceuticals, Sanofi BiotechnologiesAmgen, Amgen Europe
UPC_COA_641/2025Jul 14, 2025Sanofi BiotechnologyAmgen
APL_32765/2025Jul 11, 2025Amgen, Amgen EuropeRegeneron Pharmaceuticals

More cases involving Amgen

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 9, 2025
Case NumberFiling DatePlaintiffsDefendants
App_35200/2025Aug 21, 2025Amgen, Amgen AB, Amgen Biofarmaceutica LDA, Amgen Technology Ireland Unlimited, Amgen Zdravila DOO -
App_35086/2025Aug 20, 2025Amgen, Amgen AB, Amgen Biofarmaceutica LDA, Amgen Technology Ireland Unlimited, Amgen Zdravila DOO -
App_35087/2025Aug 20, 2025Amgen, Amgen AB, Amgen Biofarmaceutica LDA, Amgen Technology Ireland Unlimited, Amgen Zdravila DOO -

More cases involving Regeneron Pharmaceuticals

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 9, 2025
Case NumberFiling DatePlaintiffsDefendants
App_34318/2025Aug 5, 2025Regeneron Pharmaceuticals -
ORD_34329/2025Aug 5, 2025AmgenRegeneron Pharmaceuticals
App_33251/2025Jul 21, 2025Regeneron Pharmaceuticals -